Meng-jie Niu

Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs

Zhiwei Yang, S. Zhang, Ying Li, 2019, Acta Pharmacologica Sinica.

TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun

Y. Li, Zhiwei Yang, S. Zhang, 2016, Oncotarget.

Interventional therapy in sarcoidosis‐associated pulmonary arterial stenosis and pulmonary hypertension

Lingli Liu, Shengqing Li, Jian Xu, 2017, The clinical respiratory journal.

Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report

Y. Li, Shengqing Li, Jian He, 2017, Oncology letters.

Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats

Li Yang, Y. Li, Li Yang, 2018, Front. Pharmacol..

Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world

Lingli Liu, Shengqing Li, Ning Zhu, 2018, The clinical respiratory journal.

Treatment of Pulmonary Arterial Hypertension Using Initial Combination Therapy of Bosentan and Iloprost

Lingli Liu, Shengqing Li, Xinpeng Han, 2017, Respiratory Care.